INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Type 2 Diabetes & Insulin Resistance desk →

1,146 studies · page 35 of 48

2017 / Randomized controlled crossover trial

Both Salba-chia and flax seeds lowered postprandial blood glucose, but Salba-chia altered peak glucose kinetics and reduced appetite more than flax.

Fifteen healthy participants received a 50 g glucose challenge alone or supplemented with either 25 g ground Salba-chia or 31.5 g flax on three separate occasions. Both Salba-chia and flax reduced the 120-min blood glucose area under the curve by 82.5±19.7 mmol/l (P<0.001) and 60.0±19.7 mmol/l (P=0.014), respectively, relative to control. Compared with flax, Salba-chia reduced peak glucose by -0.64±0.24 mmol/l (P=0.030), increased time to peak by 11.3±3.8 min (P=0.015), and significantly reduced overall appetite score (-6±2 mm; P=0.012). Viscosity was 49.9 Pa·s for Salba-chia, 2.5 Pa·s for flax, and 0.002 Pa·s for control.

Vuksan V, Choleva L, Jovanovski E, et al. Eur J Clin Nutr, 2017. PMID 28000689

2017 / Randomized crossover trial

Adding freeze-dried strawberry powder to a high-fat meal did not alter postprandial vascular markers.

A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).

Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205

2017 / Randomized controlled trial

Salba-chia added to calorie restriction aids weight and waist loss in diabetes.

In a 6-month trial involving 77 overweight or obese adults with type 2 diabetes, participants received either Salba-chia or an oat bran control alongside a calorie-restricted regimen. Those receiving Salba-chia achieved greater weight loss (1.9 ± 0.5 kg vs. 0.3 ± 0.4 kg; P = 0.020) and greater waist circumference reductions (3.5 ± 0.7 cm vs. 1.1 ± 0.7 cm; P = 0.027). Salba-chia also produced superior decreases in C-reactive protein (P = 0.045) and increased adiponectin levels (P = 0.022).

Vuksan V, Jenkins AL, Brissette C, et al. Nutr Metab Cardiovasc Dis, 2017. PMID 28089080

2017 / Randomized controlled trial

An acute saturated fat load induced insulin resistance and increased hepatic lipid storage.

A randomized trial in 14 lean, healthy individuals evaluated the metabolic impacts of an oral palm oil challenge compared with vehicle. Palm oil lowered insulin sensitivity across the whole body by 25%, liver by 15%, and adipose tissue by 34%. It also boosted liver triglyceride stores by 35%, increased ATP levels by 16%, and elevated gluconeogenesis by 70%, while decreasing glycogenolysis by 20%.

Hernández EÁ, Kahl S, Seelig A, et al. J Clin Invest, 2017. PMID 28112681

2017 / Randomized crossover trial

Short-term carbohydrate overfeeding, without protein restriction, markedly increased circulating FGF21 levels in healthy men.

Nine healthy men were fed three diets for three days each in random order: a eucaloric control diet (CON), a carbohydrate-rich diet (+75% energy, 80 E% carbohydrate; CHO), and a fat-rich diet (+75% energy, 78 E% fat; FAT), maintaining similar absolute protein intake between CHO and CON. Plasma FGF21 increased 8-fold after CHO compared to CON (329 ± 99 vs. 39 ± 9 pg ml-1, p < 0.05), whereas FAT produced only a non-significant tendency to increase (p = 0.073). The increase in FGF21 after CHO correlated closely (r = 0.88, p < 0.01) with increased leg glucose uptake (62%, p < 0.05) and hepatic glucose production (17%, p < 0.01). CHO also decreased plasma fatty acids by 68% (p < 0.01), increased the de novo lipogenesis marker C16:1 n-7 FA by 146% (p < 0.01), and increased plasma triglycerides by 101% (p < 0.001).

Lundsgaard AM, Fritzen AM, Sjøberg KA, et al. Mol Metab, 2017. PMID 28123934

2017 / Interventional trial with wash-out period

Chronic branched chain amino acid supplementation impaired insulin sensitivity in vegans but not in omnivores.

Eight vegans and eight matched omnivores were supplemented with 15 g (women) or 20 g (men) of branched chain amino acids (BCAA) daily for 3 months, followed by a 6-month wash-out. Vegans had higher baseline insulin sensitivity (GIR: 9.6±2.4 vs 7.1±2.4 mg/kg/min), which declined following the intervention (change: -1.64 mg/kg/min [95% CI: -2.5 to -0.75]) and returned to baseline after wash-out (change: 1.65 mg/kg/min [95% CI: 0.75 to 2.54]). No GIR change was observed in omnivores, though omnivores showed increased expression of lipogenic genes in adipose tissue. Skeletal muscle respiratory chain activity increased in both groups.

Gojda J, Rossmeislová L, Straková R, et al. Eur J Clin Nutr, 2017. PMID 28145418

2017 / Randomized, placebo-controlled, double-blind parallel trial

Resveratrol supplementation for 16 weeks did not improve metabolic syndrome markers and high doses increased total and LDL cholesterol.

A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.

Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820

2017 / Randomized controlled crossover trial

A fasting-mimicking diet reduced body fat, blood pressure, and disease risk factors.

In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.

Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779

2017 / Randomized two-way crossover trial

A single night of bright light exposure significantly increased post-meal plasma glucose and insulin levels compared to dim light in healthy participants.

Seventeen healthy participants were randomized to a two-way crossover study comparing dim light (<5 lux) and bright light (>500 lux) sessions separated by at least 7 days, measuring metabolic responses around a standard evening meal. Plasma glucose and insulin levels were significantly higher post-meal during bright light compared to dim light (P = 0.02 and P = 0.001, respectively). Pre-meal plasma non-esterified fatty acid levels and salivary melatonin were significantly higher in dim light compared to bright light (P < 0.01 and P = 0.005, respectively), while plasma triglyceride levels did not differ between sessions.

Albreiki MS, Middleton B, Hampton SM Endocr Connect, 2017. PMID 28270559

2017 / Randomized controlled trial

A whole food plant-based diet reduced BMI in adults with cardiometabolic risk factors.

In a randomized controlled trial of 65 adults with overweight or obesity and cardiometabolic conditions, an ad libitum whole food plant-based diet was compared to usual care. At 6 months, mean BMI reduction was significantly greater in the diet group (difference: 3.9 kg m-2, 95% CI ±1, P < 0.0001). Total cholesterol reduction did not significantly differ between groups unless dropouts were excluded (difference: 0.56 mmol l-1, P = 0.05).

Wright N, Wilson L, Smith M, et al. Nutr Diabetes, 2017. PMID 28319109

2017 / Randomized crossover trial

Non-nutritive and sucrose-sweetened beverages showed similar 24-hour glucose profiles in healthy men

In a randomized crossover study of ten healthy men, consuming beverages sweetened with aspartame, monk fruit, stevia, or 65 g sucrose as a mid-morning preload led to no significant differences in mean 24-hour glucose, iAUC, total AUC, or 24-hour glycemic variability. Replacing one serving of a sucrose-sweetened drink with non-nutritive sweeteners had minimal influence over daily glucose measures.

Tey SL, Salleh NB, Henry CJ, et al. Eur J Clin Nutr, 2017. PMID 28378852

2017 / Randomized controlled explorative pilot trial

A 7-day fasting program reduced weight, abdominal circumference, and blood pressure in patients with type 2 diabetes at 4 months.

In an explorative trial, patients with type 2 diabetes were randomized to a 7-day fasting program (Buchinger method, ~300 kcal/day liquids) followed by dietary advice, or to usual care with dietary advice only. Of 46 enrolled participants, 32 completed the 4-month trial. After 4 months, mean weight decreased by 3.5 kg in the fasting group compared to 2.0 kg in controls (p=0.03), accompanied by a greater reduction in abdominal circumference (p=0.001). Fasting also resulted in a significant decrease in systolic (p=0.01) and diastolic (p=0.003) blood pressure, as well as increased quality of life (p=0.04), while improvements in HbA1c, insulin, and HOMA-index were non-significant.

Li C, Sadraie B, Steckhan N, et al. Exp Clin Endocrinol Diabetes, 2017. PMID 28407662

2017 / 13-day sequential laboratory intervention trial

A 5-hour delay in meal timing delayed human plasma glucose rhythms and adipose PER2 mRNA rhythms without altering central circadian markers.

Ten healthy young men completed a 13-day laboratory protocol comparing early meals (starting 0.5 hr post-wake) to late meals (starting 5.5 hr post-wake, for 6 days), followed by 37-hr constant routine assessments. Late meals did not affect master clock markers (plasma melatonin and cortisol), subjective hunger, sleepiness, plasma triglycerides, or whole blood clock gene expression. However, following late meals, plasma glucose rhythms were delayed by 5.69 ± 1.29 hr (p < 0.001), average glucose decreased by 0.27 ± 0.05 mM (p < 0.001), and adipose tissue PER2 mRNA rhythms were delayed by 0.97 ± 0.29 hr (p < 0.01).

Wehrens SMT, Christou S, Isherwood C, et al. Curr Biol, 2017. PMID 28578930

2017 / Randomized controlled trial

A hypocaloric vegetarian diet reduced subfascial thigh fat more than a conventional diet.

In a randomized trial, 74 individuals with type 2 diabetes consumed either a calorie-restricted vegetarian diet or an isocaloric conventional anti-diabetic diet for 6 months. Total leg area decreased more in the vegetarian group (-13.6 cm2 vs -9.9 cm2; p < 0.001), and subfascial fat was reduced only with the vegetarian diet (-0.82 cm2 vs -0.44 cm2; p = 0.04). Reductions in subfascial and subcutaneous fat correlated with improvements in fasting glucose and beta-cell insulin sensitivity.

Kahleova H, Klementova M, Herynek V, et al. J Am Coll Nutr, 2017. PMID 28604251

2017 / Controlled clinical trial

Avoiding night meals during simulated shift work preserved postprandial glucose metabolism.

A controlled study tested whether consuming or avoiding food at night affected glucose metabolism in 11 healthy men during four simulated night shifts. Eating at night resulted in significant increases in glucose area under the curve post breakfast on shift day 4 (p = 0.05) and upon return to day shift (p < 0.001). Conversely, the group that abstained from nighttime eating did not experience significant increases in glucose area under the curve.

Grant CL, Coates AM, Dorrian J, et al. Chronobiol Int, 2017. PMID 28635334

2017 / Clinical trial (before-and-after)

A single day of high-fat overfeeding reduced whole-body insulin sensitivity in young adults.

Fifteen healthy adults completed an oral glucose tolerance test before and after one day of consuming a diet providing 78% excess energy with 68% of calories from fat. Postprandial glucose area under the curve rose by 17.1% (p < 0.0001) and insulin area under the curve rose by 16.4% (p = 0.007). Whole-body insulin sensitivity measured by the Matsuda index decreased by 28% (p = 0.001).

Parry SA, Woods RM, Hodson L, et al. Nutrients, 2017. PMID 28758920

2017 / Randomized crossover trial

Breakfast skipping altered clock gene expression and correlated with increased postprandial glycemic response.

In a randomized crossover trial, 18 healthy individuals and 18 individuals with type 2 diabetes completed a test day with breakfast and lunch and a test day with lunch only. Omission of breakfast altered postprandial clock and metabolic gene expression in both groups, showing distinct expression changes in genes such as Per1, Cry1, Rora, Sirt1, and Bmal1. Authors concluded that breakfast acutely affects clock gene expression leading to normal oscillation, while breakfast skipping adversely affects clock gene expression and is correlated with increased postprandial glycemic response.

Jakubowicz D, Wainstein J, Landau Z, et al. Diabetes Care, 2017. PMID 28830875

2017 / Randomized controlled trial

Blueberry smoothies reduced oxidative stress and modulated immune markers in metabolic syndrome.

Adults with metabolic syndrome were randomized to consume either freeze-dried blueberry smoothies or a placebo twice daily for six weeks. Blueberry supplementation reduced superoxide and total reactive oxygen species in monocytes and whole blood compared to placebo (p ≤ 0.05). It also raised myeloid dendritic cell counts, decreased monocyte expression of TNF-alpha, IL-6, and TLR4, and decreased circulating GMCSF levels (p ≤ 0.05).

Nair AR, Mariappan N, Stull AJ, et al. Food Funct, 2017. PMID 29019365

2017 / Randomized crossover trial

A mixed berry drink lowered cholesterol and improved working memory in older adults

Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.

Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041

2017 / Prospective randomized placebo-controlled study

Moringa oleifera leaf capsules (8 g/day) had no significant effect on glycemic control in therapy-naïve type 2 diabetes patients.

Thirty-two therapy-naïve type 2 diabetes patients were randomized to receive either 8 grams per day of Moringa oleifera (MO) leaf capsules or placebo for 4 weeks. There was no significant difference in FPG and HbA1C between groups, and no adverse effects were observed. The MO leaf group experienced a 5 mmHg reduction in systolic blood pressure compared to baseline, but this change was not statistically significant.

Taweerutchana R, Lumlerdkij N, Vannasaeng S, et al. Evid Based Complement Alternat Med, 2017. PMID 29317895

2016 / Randomized controlled trial

Marjoram tea lowered DHEA-S and improved insulin resistance markers in women with PCOS.

In a randomized, double-blind, placebo-controlled pilot study, 25 women with polycystic ovary syndrome consumed marjoram tea (n=14) or placebo tea (n=11) twice daily for one month. Marjoram intake significantly lowered DHEA-S by a mean of 1.4 μmol/L and fasting insulin by 1.9 μU/mL within the group. Relative to placebo, reductions were statistically significant for DHEA-S (P=0.05) and HOMA-IR (P<0.05), while fasting insulin changes did not differ significantly (P=0.08).

Haj-Husein I, Tukan S, Alkazaleh F J Hum Nutr Diet, 2016. PMID 25662759

2016 / Randomized controlled trial

Ginger supplementation decreased body mass index and insulin resistance in obese women

In a randomized, double-blind trial, 80 obese women received 2 g daily of ginger powder or placebo for 12 weeks. Ginger supplementation significantly decreased body mass index, serum insulin, and HOMA-IR index, while increasing QUICKI values compared to placebo. Decreases in leptin, resistin, and glucose occurred in both cohorts without significant differences between groups, whereas body composition and adiponectin concentrations remained unchanged.

Ebrahimzadeh Attari V, Ostadrahimi A, Asghari Jafarabadi M, et al. Eur J Nutr, 2016. PMID 26318445

2016 / Randomized crossover trial

Light and dark roast coffees similarly increased acute insulin responses over water

In a randomized crossover trial, 11 healthy volunteers ingested 300 mL of light roast coffee, dark roast coffee, or water prior to an oral glucose tolerance test. Neither coffee altered overall glucose area under the curve compared with water, though dark roast produced higher glucose at 60 minutes. Both roasts significantly raised insulin concentrations and lowered insulin sensitivity indices relative to water, without differing from each other.

Rakvaag E, Dragsted LO Eur J Nutr, 2016. PMID 26342706

2016 / Double-blind, randomized, crossover trial

Five weeks of resveratrol supplementation did not affect GLP-1 secretion, gastric emptying, or glycemic control in type 2 diabetes.

In a randomized, double-blind crossover trial, 14 patients with diet-controlled type 2 diabetes received resveratrol (500 mg twice daily) or placebo for two 5-week periods separated by a 5-week washout. Fasting and postprandial blood glucose, plasma total GLP-1, and gastric emptying were similar at each assessment, and changes from weeks 0 to 5 did not differ between resveratrol and placebo. Changes in HbA1c, daily energy intake, and body weight after 5 weeks also showed no significant differences between treatments.

Thazhath SS, Wu T, Bound MJ, et al. Am J Clin Nutr, 2016. PMID 26607942